IBDEI19J ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22378,1,4,0)
 ;;=4^290.0
 ;;^UTILITY(U,$J,358.3,22378,1,5,0)
 ;;=5^Dementia, Senile
 ;;^UTILITY(U,$J,358.3,22378,2)
 ;;=^31703
 ;;^UTILITY(U,$J,358.3,22379,0)
 ;;=780.4^^125^1392^110
 ;;^UTILITY(U,$J,358.3,22379,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22379,1,4,0)
 ;;=4^780.4
 ;;^UTILITY(U,$J,358.3,22379,1,5,0)
 ;;=5^Vertigo
 ;;^UTILITY(U,$J,358.3,22379,2)
 ;;=^35946
 ;;^UTILITY(U,$J,358.3,22380,0)
 ;;=345.90^^125^1392^105
 ;;^UTILITY(U,$J,358.3,22380,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22380,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,22380,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,22380,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,22381,0)
 ;;=355.1^^125^1392^75
 ;;^UTILITY(U,$J,358.3,22381,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22381,1,4,0)
 ;;=4^355.1
 ;;^UTILITY(U,$J,358.3,22381,1,5,0)
 ;;=5^Meralgia Paresthetica
 ;;^UTILITY(U,$J,358.3,22381,2)
 ;;=^265141
 ;;^UTILITY(U,$J,358.3,22382,0)
 ;;=340.^^125^1392^83
 ;;^UTILITY(U,$J,358.3,22382,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22382,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,22382,1,5,0)
 ;;=5^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,22382,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,22383,0)
 ;;=729.2^^125^1392^84
 ;;^UTILITY(U,$J,358.3,22383,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22383,1,4,0)
 ;;=4^729.2
 ;;^UTILITY(U,$J,358.3,22383,1,5,0)
 ;;=5^Neuropathic Pain
 ;;^UTILITY(U,$J,358.3,22383,2)
 ;;=Neuropathic Pain^82605
 ;;^UTILITY(U,$J,358.3,22384,0)
 ;;=053.19^^125^1392^92
 ;;^UTILITY(U,$J,358.3,22384,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22384,1,4,0)
 ;;=4^053.19
 ;;^UTILITY(U,$J,358.3,22384,1,5,0)
 ;;=5^Post-Herpetic Neuralgia
 ;;^UTILITY(U,$J,358.3,22384,2)
 ;;=^266544
 ;;^UTILITY(U,$J,358.3,22385,0)
 ;;=310.9^^125^1392^85
 ;;^UTILITY(U,$J,358.3,22385,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22385,1,4,0)
 ;;=4^310.9
 ;;^UTILITY(U,$J,358.3,22385,1,5,0)
 ;;=5^Organic Brain Syndrome
 ;;^UTILITY(U,$J,358.3,22385,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,22386,0)
 ;;=332.0^^125^1392^88
 ;;^UTILITY(U,$J,358.3,22386,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22386,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,22386,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,22386,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,22387,0)
 ;;=250.60^^125^1392^89
 ;;^UTILITY(U,$J,358.3,22387,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22387,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,22387,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,22387,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,22388,0)
 ;;=356.9^^125^1392^91
 ;;^UTILITY(U,$J,358.3,22388,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22388,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,22388,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,22388,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,22389,0)
 ;;=780.2^^125^1392^106
 ;;^UTILITY(U,$J,358.3,22389,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22389,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,22389,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,22389,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,22390,0)
 ;;=724.3^^125^1392^102
 ;;^UTILITY(U,$J,358.3,22390,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22390,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,22390,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,22390,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,22391,0)
 ;;=780.39^^125^1392^103
 ;;^UTILITY(U,$J,358.3,22391,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22391,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,22391,1,5,0)
 ;;=5^Seizure
 ;;^UTILITY(U,$J,358.3,22391,2)
 ;;=^28162
 ;;
 ;;$END ROU IBDEI19J
